Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system
出版年份 2014 全文链接
标题
Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system
作者
关键词
-
出版物
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 307, Issue 4, Pages H477-H492
出版商
American Physiological Society
发表日期
2014-06-16
DOI
10.1152/ajpheart.00209.2014
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Do incretins improve endothelial function?
- (2014) Jun-ichi Oyama et al. Cardiovascular Diabetology
- Dipeptidyl Peptidase-4 Inhibitors and Cardiovascular Outcomes: Meta-Analysis of Randomized Clinical Trials with 55,141 Participants
- (2014) Shiying Wu et al. Cardiovascular Therapeutics
- A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position
- (2014) C. B. Giorda et al. DIABETES OBESITY & METABOLISM
- GLP-1-Based Strategies: A Physiological Analysis of Differential Mode of Action
- (2014) Rémy Burcelin et al. PHYSIOLOGY
- Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies
- (2014) L. Li et al. BMJ-British Medical Journal
- Uric Acid - Key Ingredient in the Recipe for Cardiorenal Metabolic Syndrome
- (2014) Kunal Chaudhary et al. CardioRenal Medicine
- Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease
- (2013) Jennifer B. Green et al. AMERICAN HEART JOURNAL
- Perivascular adipose tissue-derived adiponectin activates BKCa channels to induce anticontractile responses
- (2013) Fiona M. Lynch et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Renal Impairment Has No Clinically Relevant Effect on the Long-Term Exposure of Linagliptin in Patients With Type 2 Diabetes
- (2013) Christian Friedrich et al. AMERICAN JOURNAL OF THERAPEUTICS
- Physiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2
- (2013) Daniel J. Drucker et al. Annual Review of Physiology
- Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe−/− mice
- (2013) Mathias Burgmaier et al. ATHEROSCLEROSIS
- Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner
- (2013) Derek J Hausenloy et al. Cardiovascular Diabetology
- Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report
- (2013) Yoko Noda et al. Cardiovascular Diabetology
- Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
- (2013) Yuji Ishibashi et al. Cardiovascular Diabetology
- Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials
- (2013) Maximilian von Eynatten et al. Cardiovascular Diabetology
- The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
- (2013) Susana Ravassa et al. Cardiovascular Diabetology
- Cardiovascular pleiotropic actions of DPP-4 inhibitors: A step at the cutting edge in understanding their additional therapeutic potentials
- (2013) Pitchai Balakumar et al. CELLULAR SIGNALLING
- Circulating Dipeptidyl Peptidase IV Activity Correlates With Cardiac Dysfunction in Human and Experimental Heart Failure
- (2013) Leonardo dos Santos et al. Circulation-Heart Failure
- Immune mechanisms in hypertension and vascular injury
- (2013) Ernesto L. Schiffrin CLINICAL SCIENCE
- MMP-9 Inhibitors in the Brain: Can Old Bullets Shoot New Targets?
- (2013) Leszek Kaczmarek CURRENT PHARMACEUTICAL DESIGN
- Incretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological Pitfalls
- (2013) D. J. Drucker DIABETES
- Mineralocorticoid Receptor-Mediated Vascular Insulin Resistance: An Early Contributor to Diabetes-Related Vascular Disease?
- (2013) S. B. Bender et al. DIABETES
- Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA trial
- (2013) Julio Rosenstock et al. Diabetes & Vascular Disease Research
- Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction
- (2013) P.-H. Groop et al. DIABETES CARE
- A Critical Analysis of the Clinical Use of Incretin-Based Therapies: The benefits by far outweigh the potential risks
- (2013) M. A. Nauck DIABETES CARE
- A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?
- (2013) P. C. Butler et al. DIABETES CARE
- Cardiovascular safety of the dipetidyl peptidase-4 inhibitor alogliptin in type 2 diabetes mellitus
- (2013) W. B. White et al. DIABETES OBESITY & METABOLISM
- Clinical Practice Considerations and Review of the Literature for the Use of DPP-4 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease
- (2013) German Ramirez et al. Endocrine Practice
- Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
- (2013) Nasib Ervinna et al. ENDOCRINOLOGY
- Dipeptidylpeptidase Inhibition Is Associated with Improvement in Blood Pressure and Diastolic Function in Insulin-Resistant Male Zucker Obese Rats
- (2013) Annayya R. Aroor et al. ENDOCRINOLOGY
- Diabetes Mellitus and Vascular Disease
- (2013) James R. Sowers HYPERTENSION
- Cellular and Molecular Mechanisms of Arterial Stiffness Associated With Obesity
- (2013) Jane A. Leopold HYPERTENSION
- Arterial Stiffening Precedes Systolic Hypertension in Diet-Induced Obesity
- (2013) Robert M. Weisbrod et al. HYPERTENSION
- CD26/DPP4 Levels in Peripheral Blood and T Cells in Patients With Type 2 Diabetes Mellitus
- (2013) Sang Ah Lee et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Does drug therapy reverse endothelial progenitor cell dysfunction in diabetes?
- (2013) Cyrus V. Desouza JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Effects of telmisartan and linagliptin when used in combination on blood pressure and oxidative stress in rats with 2-kidney-1-clip hypertension
- (2013) Lyubov Chaykovska et al. JOURNAL OF HYPERTENSION
- Is endothelial dysfunction more deleterious than podocyte injury in diabetic nephropathy?
- (2013) Takahiko Nakagawa KIDNEY INTERNATIONAL
- Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance
- (2013) Annayya R. Aroor et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke
- (2013) Mayank Chaturvedi et al. MOLECULAR NEUROBIOLOGY
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of insulin resistance in endothelial dysfunction
- (2013) Ranganath Muniyappa et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Diabetes Mellitus
- (2013) Jane C. Khoury et al. STROKE
- DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes
- (2013) Annayya Aroor et al. CardioRenal Medicine
- Dipeptidyl Peptidase‐4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow‐Mediated Vasodilatation in Type 2 Diabetic Patients
- (2013) Makoto Ayaori et al. Journal of the American Heart Association
- Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: Cause or association?
- (2012) William E. Moody et al. ATHEROSCLEROSIS
- An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: Potential implications in cardiovascular disease
- (2012) Jixin Zhong et al. ATHEROSCLEROSIS
- Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
- (2012) Kerry Hunter et al. BMC NEUROSCIENCE
- Dipeptidyl peptidase-4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells
- (2012) Chun-Yao Huang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data
- (2012) Michael E Cobble et al. Cardiovascular Diabetology
- Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme
- (2012) Odd Johansen et al. Cardiovascular Diabetology
- Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition
- (2012) Swenja Kröller-Schön et al. CARDIOVASCULAR RESEARCH
- DPP-4 Inhibition Attenuates Cardiac Dysfunction and Adverse Remodeling Following Myocardial Infarction in Rats with Experimental Diabetes
- (2012) Kim Alexander Connelly et al. Cardiovascular Therapeutics
- Dipeptidyl Peptidase-4 Modulates Left Ventricular Dysfunction in Chronic Heart Failure via Angiogenesis-Dependent and -Independent Actions
- (2012) Toshimasa Shigeta et al. CIRCULATION
- Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors
- (2012) Larry K. Golightly et al. CLINICAL PHARMACOKINETICS
- Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease
- (2012) Usha Panchapakesan et al. CLINICAL SCIENCE
- The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain: A Comparison With Glimepiride
- (2012) V. Darsalia et al. DIABETES
- Glucagon-Like Peptide 1 Recruits Microvasculature and Increases Glucose Use in Muscle via a Nitric Oxide-Dependent Mechanism
- (2012) W. Chai et al. DIABETES
- Cardiovascular effects of the DPP-4 inhibitors
- (2012) Tessey Jose et al. Diabetes & Vascular Disease Research
- Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials
- (2012) M. Monami et al. DIABETES OBESITY & METABOLISM
- Cardiovascular Biology of the Incretin System
- (2012) John R. Ussher et al. ENDOCRINE REVIEWS
- Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Protects Endothelial Function in Hypertension Through a Glucagon–Like Peptide 1–Dependent Mechanism
- (2012) Limei Liu et al. HYPERTENSION
- The novel DPP-4 inhibitors linagliptin and BI 14361 reduce infarct size after myocardial ischemia/reperfusion in rats
- (2012) Berthold Hocher et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Prevalence of Obesity and Trends in Body Mass Index Among US Children and Adolescents, 1999-2010
- (2012) Cynthia L. Ogden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010
- (2012) Katherine M. Flegal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Enhanced Nitric Oxide Release and Reduced Blood Pressure and sICAM-1 Levels in Hypertensive Rats
- (2012) R. Preston Mason et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes
- (2012) Yoshiaki Kubota et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Significance of circulating endothelial progenitor cells in patients with fracture healing process
- (2012) Xin-Long Ma et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E–Deficient Mice
- (2012) Junichi Matsubara et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular effects of antidiabetic agents: focus on blood pressure effects of incretin-based therapies
- (2012) Nancy J. Brown Journal of the American Society of Hypertension
- DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy
- (2012) Markus L. Alter et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Renal and Cardiac Effects of DPP-4 Inhibitors from Preclinical Development to Clinical Research
- (2012) Berthold Hocher et al. KIDNEY & BLOOD PRESSURE RESEARCH
- 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial
- (2012) Baptist Gallwitz et al. LANCET
- Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
- (2012) Matthias Kern et al. PLoS One
- Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome
- (2012) Annayya R. Aroor et al. CardioRenal Medicine
- Endothelial Progenitor Cell Dysfunction in Cardiovascular Diseases: Role of Reactive Oxygen Species and Inflammation
- (2012) Chih-Pei Lin et al. Biomed Research International
- Vascular Inflammatory Cells in Hypertension
- (2012) David G. Harrison et al. Frontiers in Physiology
- Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus
- (2012) Thomas Rauch et al. Diabetes Therapy
- Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytes
- (2011) Susana Ravassa et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- ROS-induced ROS release in vascular biology: redox-redox signaling
- (2011) Natalya S. Zinkevich et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Interleukin-10 Released by CD4 + CD25 + Natural Regulatory T Cells Improves Microvascular Endothelial Function Through Inhibition of NADPH Oxidase Activity in Hypertensive Mice
- (2011) Modar Kassan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats
- (2011) Seema Briyal et al. BRAIN RESEARCH
- Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
- (2011) Meimei Yin et al. Cardiovascular Diabetology
- Impaired Insulin Signaling in Endothelial Cells Reduces Insulin-Induced Glucose Uptake by Skeletal Muscle
- (2011) Tetsuya Kubota et al. Cell Metabolism
- Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
- (2011) Zubair Shah et al. CIRCULATION
- Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats
- (2011) Vladimer Darsalia et al. CLINICAL SCIENCE
- Neuroprotective properties of GLP-1: theoretical and practical applications
- (2011) Jens Juul Holst et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Pleiotropic Effects of ARB in Vascular Endothelial Progenitor Cells
- (2011) Katsuhisa Matsuura et al. Current Vascular Pharmacology
- Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
- (2011) D. Lamers et al. DIABETES
- Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
- (2011) J. Shirakawa et al. DIABETES
- Vildagliptin Improves Endothelium-Dependent Vasodilatation in Type 2 Diabetes
- (2011) P. C. M. van Poppel et al. DIABETES CARE
- Endothelial Dysfunction in Diabetes: The role of reparatory mechanisms
- (2011) A. Avogaro et al. DIABETES CARE
- Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes
- (2011) A. J. Tremblay et al. DIABETES OBESITY & METABOLISM
- Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin*
- (2011) U. Graefe-Mody et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
- (2011) R. Kodera et al. DIABETOLOGIA
- Pharmacology of Dipeptidyl Peptidase-4 Inhibitors
- (2011) Roberta Baetta et al. DRUGS
- Telmisartan Improves Insulin Resistance and Modulates Adipose Tissue Macrophage Polarization in High-Fat-Fed Mice
- (2011) Shiho Fujisaka et al. ENDOCRINOLOGY
- Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies
- (2011) Michael Elashoff et al. GASTROENTEROLOGY
- T Regulatory Lymphocytes Prevent Aldosterone-Induced Vascular Injury
- (2011) Daniel A. Kasal et al. HYPERTENSION
- DPP-4 (CD26) Inhibitor Alogliptin Inhibits Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice
- (2011) Nga N Ta et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- Ischemia-induced changes in glucagon-like peptide-1 receptor and neuroprotective effect of its agonist, exendin-4, in experimental transient cerebral ischemia
- (2011) Choong Hyun Lee et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Pancreatic Ultrastructural Enhancement Due to Telmisartan Plus Sitagliptin Treatment in Diet-Induced Obese C57BL/6 Mice
- (2011) Vanessa Souza-Mello et al. PANCREAS
- Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product–receptor axis
- (2011) Takanori Matsui et al. PHARMACOLOGICAL RESEARCH
- Effects of DPP-4 Inhibitors on the Heart in a Rat Model of Uremic Cardiomyopathy
- (2011) Lyubov Chaykovska et al. PLoS One
- The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients
- (2011) Lasse Bremholm et al. REGULATORY PEPTIDES
- Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Decreases Systolic Blood Pressure in Japanese Hypertensive Patients with Type 2 Diabetes
- (2011) Susumu Ogawa et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways
- (2011) Zubair Shah et al. VASCULAR PHARMACOLOGY
- Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1
- (2011) Gian Paolo Fadini et al. VASCULAR PHARMACOLOGY
- Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program
- (2011) Adam Whaley-Connell et al. CardioRenal Medicine
- The Role of Overweight and Obesity in the Cardiorenal Syndrome
- (2011) James R. Sowers et al. CardioRenal Medicine
- Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats
- (2010) Yasushi Kirino et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA
- (2010) Yumei Ye et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Glucagon-Like Peptide 1 Prevents Reactive Oxygen Species–Induced Endothelial Cell Senescence Through the Activation of Protein Kinase A
- (2010) Hisko Oeseburg et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The RAGE Axis
- (2010) Shi Fang Yan et al. CIRCULATION RESEARCH
- Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet
- (2010) Vanessa Souza-Mello et al. CLINICAL SCIENCE
- Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice
- (2010) M. Sauve et al. DIABETES
- The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes: Possible role of stromal-derived factor-1
- (2010) G. P. Fadini et al. DIABETES CARE
- Pharmacokinetics of dipeptidylpeptidase-4 inhibitors
- (2010) A. J. Scheen DIABETES OBESITY & METABOLISM
- Potential manipulation of endothelial progenitor cells in diabetes and its complications
- (2010) G. P. Fadini et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control
- (2010) P. Anagnostis et al. DIABETES OBESITY & METABOLISM
- Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial
- (2010) S. Del Prato et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells
- (2010) I. Hadjiyanni et al. DIABETOLOGIA
- Glucagon-Like Peptide (GLP)-1(9-36)Amide-Mediated Cytoprotection Is Blocked by Exendin(9-39) Yet Does Not Require the Known GLP-1 Receptor
- (2010) Kiwon Ban et al. ENDOCRINOLOGY
- Interactive Hemodynamic Effects of Dipeptidyl Peptidase-IV Inhibition and Angiotensin-Converting Enzyme Inhibition in Humans
- (2010) Annis Marney et al. HYPERTENSION
- Reactive Oxygen Species, NADPH Oxidases, and Hypertension
- (2010) Srinivasa Raju Datla et al. HYPERTENSION
- Nebivolol Improves Diastolic Dysfunction and Myocardial Remodeling Through Reductions in Oxidative Stress in the Zucker Obese Rat
- (2010) Xinli Zhou et al. HYPERTENSION
- Dipeptidyl Peptidase IV Inhibition Alters the Hemodynamic Response to Angiotensin-Converting Enzyme Inhibition in Humans With the Metabolic Syndrome
- (2010) Edwin K. Jackson HYPERTENSION
- Phenotypic and functional switch of macrophages induced by regulatory CD4+ CD25+ T cells in mice
- (2010) Guangwei Liu et al. IMMUNOLOGY AND CELL BIOLOGY
- Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats
- (2010) Bruna PM Pacheco et al. JOURNAL OF HYPERTENSION
- Elevated Proinflammatory Cytokine Production by a Skewed T Cell Compartment Requires Monocytes and Promotes Inflammation in Type 2 Diabetes
- (2010) M. Jagannathan-Bogdan et al. JOURNAL OF IMMUNOLOGY
- Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
- (2010) Richard E Pratley et al. LANCET
- Effects of Sitagliptin Treatment on Dysmetabolism, Inflammation, and Oxidative Stress in an Animal Model of Type 2 Diabetes (ZDF Rat)
- (2010) Liliana Ferreira et al. MEDIATORS OF INFLAMMATION
- Endothelial dysfunction as a potential contributor in diabetic nephropathy
- (2010) Takahiko Nakagawa et al. Nature Reviews Nephrology
- Subclinical Regional Left Ventricular Dysfunction in Obese Patients With and Without Hypertension or Hypertrophy
- (2010) José L.F. Santos et al. Obesity
- Aldosterone: Role in the Cardiometabolic Syndrome and Resistant Hypertension
- (2010) Adam Whaley-Connell et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin – diabetes control and potential adverse events
- (2009) Bo Ahrén BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression
- (2009) Yuji Ishibashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Increased Plasma Dipeptidyl Peptidase IV (DPP IV) Activity and Decreased DPP IV Activity of Visceral But Not Subcutaneous Adipose Tissue in Impaired Glucose Tolerance Rats Induced by High-Fat or High-Sucrose Diet
- (2009) Yasushi Kirino et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- On the origin of serum CD26 and its altered concentration in cancer patients
- (2009) Oscar J. Cordero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction
- (2009) Marc-Michael Zaruba et al. Cell Stem Cell
- Proinflammatory Phenotype of Perivascular Adipocytes
- (2009) Tapan K. Chatterjee et al. CIRCULATION RESEARCH
- Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus
- (2009) Mikael Kjaer Poulsen et al. Circulation-Cardiovascular Imaging
- Ten Putative Contributors to the Obesity Epidemic
- (2009) Emily J. McAllister et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
- (2009) M. H. Noyan-Ashraf et al. DIABETES
- The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice
- (2009) J. Hsieh et al. DIABETOLOGIA
- The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease
- (2009) Shi Fang Yan et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Interleukin 17 Promotes Angiotensin II–Induced Hypertension and Vascular Dysfunction
- (2009) Meena S. Madhur et al. HYPERTENSION
- Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters
- (2009) Markus Feuerer et al. NATURE MEDICINE
- Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
- (2009) Alison Hamilton et al. NEUROREPORT
- Dipeptydil peptidase-4 inhibitors in type 2 diabetes: A meta-analysis of randomized clinical trials
- (2009) M. Monami et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Early Cardiac Abnormalities in Obese Children: Importance of Obesity Per Se Versus Associated Cardiovascular Risk Factors
- (2009) Nienke van Putte-Katier et al. PEDIATRIC RESEARCH
- The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters
- (2009) Lasse Bremholm et al. REGULATORY PEPTIDES
- Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
- (2009) Roger Yazbeck et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways
- (2008) Kiwon Ban et al. CIRCULATION
- Treatment of patients with diabetes with GLP-1 analogues or DPP-4- inhibitors: a hot topic for cardiologists?
- (2008) Thomas Jax Clinical Research in Cardiology
- Sitagliptin Augments Sympathetic Enhancement of the Renovascular Effects of Angiotensin II in Genetic Hypertension
- (2008) Edwin K. Jackson et al. HYPERTENSION
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of BI 1356, an Inhibitor of Dipeptidyl Peptidase 4, in Healthy Male Volunteers
- (2008) S. Hüttner et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Blood Pressure in Nondiabetic Patients With Mild to Moderate Hypertension
- (2008) Goutam C. Mistry et al. JOURNAL OF CLINICAL PHARMACOLOGY
- (R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a Novel Xanthine-Based Dipeptidyl Peptidase 4 Inhibitor, Has a Superior Potency and Longer Duration of Action Compared with Other Dipeptidyl Peptidase-4 Inhibitors
- (2008) L. Thomas et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease
- (2008) Victoria Cachofeiro et al. KIDNEY INTERNATIONAL
- Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
- (2008) Peter Gæde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
- (2007) Joseph D. Raffetto et al. BIOCHEMICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation